Tag: clinical-trial

New drug provides fresh hope for cancer patients

| February 25, 2016 | 0 Comments

A new type of cancer therapy has produced dramatic results in patients with advanced leukaemia in an early-phase clinical trial, scientists say. Approximately 15 per cent of acute myeloid leukaemia patients have a mutated form of the IDH2 gene.

Continue Reading

MSK begins CAR T cell clinical trial for children with relapsed or treatment-resistant ALL

| April 12, 2015 | 0 Comments

Researchers from Memorial Sloan Kettering Cancer Center are pioneering a new groundbreaking clinical trial for children and young adults with relapsed or treatment-resistant acute lymphocytic leukemia (ALL) by using one of the most promising methods of cancer treatment today, chimeric antigen receptor (CAR) T cells.

Continue Reading

Memorial Sloan Kettering Opens First Pediatric CAR T Cell Clinical Trial

| April 10, 2015 | 0 Comments

Researchers from Memorial Sloan Kettering Cancer Center (MSK) are pioneering a new groundbreaking clinical trial for children and young adults with relapsed or treatment-resistant acute lymphocytic leukemia (ALL) by using one of the most promising methods of cancer treatment today, chimeric antigen receptor (CAR) T cells.

Continue Reading

New targeted treatments extend lives of Colorado cancer patients

| April 2, 2015 | 0 Comments

Polly Rogers, a lung cancer patient enrolled in a clinical trial, is checked by Dr. Ross Camidge, who leads the lung cancer trials at the University of Colorado Cancer Center.

Continue Reading

Meridian Health Partners with Rutgers Cancer Institute of New Jersey to Expand Personalized Treatment Offerings to …

| March 31, 2015 | 0 Comments

Rutgers Cancer Institute of New Jersey is joining forces with Meridian Health in offering patients with rare forms of cancer or with cancer that no longer responds to standard treatment access to a clinical trial. The research will use genomic analysis to identify abnormal changes in the genetic make-up of the cancer

Continue Reading

Kaiser Vallejo involved in new clinical trials to personalize cancer treatment

| March 10, 2015 | 0 Comments

A Kaiser Vallejo doctor is heading up this region’s part of a clinical trial that could revolutionize how cancer treatments are selected, Kaiser officials announced.

Continue Reading

Local Doctors Using New Breast Cancer Treatment

| March 9, 2015 | 0 Comments

A groundbreaking clinical trial underway in Memphis is hoping to serve as a life-saver for cancer patients.

Continue Reading

Advanced thyroid cancer responds to targeted therapy with sunitinib

| March 8, 2015 | 0 Comments

In patients with advanced thyroid cancer, sunitinib, a drug approved for treatment of several other cancers, showed significant cancer-fighting activity t, a new phase 2 clinical trial has found.

Continue Reading

Clinical trial for solid tumors with novel small molecule agent

| March 4, 2015 | 0 Comments

Rutgers Cancer Institute of New Jersey is offering a clinical trial examining the investigational treatment known as ONC201 in patients with solid tumors whose cancer no longer responds to standard therapy. Prior research on the study drug suggests that it may be capable of turning off proteins that maintain tumor growth and and may help kill cancer cells while sparing normal ones.

Continue Reading

Rutgers Cancer Institute of New Jersey Offers Clinical Trial for Solid Tumors with Novel Small Molecule Agent

| March 4, 2015 | 0 Comments

Rutgers Cancer Institute of New Jersey is offering a clinical trial examining the investigational treatment known as ONC201 in patients with solid tumors whose cancer no longer responds to standard therapy. Prior research on the study drug suggests that it may be capable of turning off proteins that maintain tumor growth and and may help kill cancer cells while sparing normal ones.

Continue Reading